Key Points of This Discussion】New classifications, trial eligibility, and Japanese approval conditions are separate pieces of ...
A focused update of the European Society of Cardiology (ESC) Heart Failure Guidelines is published online today in European Heart Journal following the results of major new trials that should change ...
ESC 2021: With ESC's new heart failure endorsement, AstraZeneca's blockbuster Farxiga is flying high
At the European Society of Cardiology Congress, AstraZeneca unveiled data showing Farxiga's kidney benefits in patients with and without heart failure. (Fierce Pharma) () When the European Society of ...
Two years is a long time in the world of heart failure (HF) management, enough to see publication of more than a dozen studies with insights that would supplant and expand key sections a far-reaching ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results